Open AccessHigh moxifloxacin cross-resistance levels among “newly identified” ofloxacin-resistant multidrug-resistant tuberculosis patients from South India: A ticking bomb or a tricky challenge?
Author(s) -
Praveen Sanker,
Anjana Satheesan,
Anusree P Ambika,
Vishnu T Santhosh,
Ravikrishnan Balakrishnan,
Sunil Kumar Mrithunjayan
Publication year - 2017
Publication title -
biomedical and biotechnology research journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.214
H-Index - 5
eISSN - 2588-9842
pISSN - 2588-9834
DOI - 10.4103/bbrj.bbrj_7_17
Subject(s) - ofloxacin , moxifloxacin , gatifloxacin , medicine , tuberculosis , rifampicin , multiple drug resistance , drug resistance , cross resistance , capreomycin , antibiotics , pharmacology , microbiology and biotechnology , ciprofloxacin , virology , ethambutol , biology , pathology